The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Paper Diagnostics Global Market Report 2024, the paper diagnostics market is expected to show promising growth in the forecast period.

Strong Growth Trajectory

• The paper diagnostics market has experienced robust growth.
• From $9.16 billion in 2023, it surged to $10.01 billion in 2024, with a CAGR of 9.2%.

Drivers of Historic Growth

• Need for affordable healthcare.
• Global health crisis preparedness.
• Point-of-care testing for chronic diseases.
• Diagnostic applications in resource-limited settings.
• Rapid results for timely decision-making.
• Increased focus on preventive healthcare.

Anticipated Growth in Forecast Period

• Expected to reach $14.49 billion in 2028, with a CAGR of 9.7%.
• Driven by advancements in paper-based biosensors, integration with wearable health devices, growth in personalized medicine, expansion of telehealth services, demand for early cancer detection, expansion of veterinary diagnostics, government initiatives for preventive healthcare.

Emerging Trends

• Advancements in paper-based technologies.
• Technological convergence in diagnostics.
• Chronic disease management apps.
• Multiplexing capabilities.
• Use of microfluidics in paper devices.
• Integration of smartphone technology.

Rising Heart Disease Prevalence Fuels Market Growth

• Cardiovascular diseases drive demand for paper diagnostics.
• Microfluidic paper-based devices aid in the diagnosis of heart conditions.
• Statistics Canada reports a notable increase in heart disease-related deaths in 2021, emphasizing the market’s significance.

Key Players and Market Landscape

• Major companies include Navigene, Siemens Healthcare GmbH, Arkray Inc., and more.
• Diverse product offerings cater to various diagnostic needs.

View More On The Paper Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/paper-diagnostics-global-market-report

Launch of Rapid POC Test

• Mylab Discovery Solutions introduces rapid point-of-care tests for detecting dengue infections.
• Tests offer quick results within 15-20 minutes without laboratory setup.
• Differentiation between IgM and IgG antibodies aids in effective disease management.

Partnerships and Developments

• Servier partners with QIAGEN to develop companion diagnostic test for detecting IDH1 mutations in Acute Myeloid Leukemia (AML) patients.
• Collaboration driven by superior results from clinical phase 3 data.
• Focus on empowering healthcare professionals with accurate diagnostic tools.

Market Segmentation

1. By Product: Dipsticks, Lateral Flow Assays: Paper Based Microfluidics
2. By Device Type: Monitoring Devices, Diagnostic Devices
3. By Application: Environmental Monitoring, Clinical Diagnostics, Food Quality Testing
4. By End-User: Home Healthcare, Assisted Living Healthcare Facilities, Hospital And Clinics

Regional Dynamics

• North America leads the market share in 2023.
• Asia-Pacific emerges as the fastest-growing region in the forecast period.

The paper diagnostics market is not just about growth but about innovation, accessibility, and improved healthcare outcomes. As the world grapples with health challenges, paper diagnostics play a crucial role in providing timely and accurate diagnostic solutions. With advancements in technology and strategic collaborations, the paper diagnostics market continues to evolve, promising a future of enhanced healthcare delivery and disease management.

Request A Sample Of The Global Paper Diagnostics Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=8582&type=smp